Why I Switched From Hims to a Direct Compounding Pharmacy

A responsible read on FormBlends starts with mechanism, side effects, access, and monitoring rather than promises. That frame keeps the discussion useful for patients without pretending the evidence is stronger than it is.

This is the post I wrote after finishing my switch, partly to document it for myself and partly because I’ve been asked the same questions enough times that writing it down felt responsible. The provider I left was Hims. The provider I use now is the one I’ll describe below. The reasons probably apply to a lot of switching decisions in this market right now.

Compliance reminder: compounded tirzepatide is not FDA-approved. The branded versions (Mounjaro, Zepbound) are. Compounded preparations come from licensed 503A/503B pharmacies for individual patients based on prescriber clinical judgment. The regulatory category is part of why pricing and provider models look the way they do.

The Shipping Delay That Made Up My Mind

On a Tuesday in March, Marcus, a 41-year-old project manager in Raleigh, texted me a screenshot of his Hims dashboard showing “shipment processing” for the sixth straight day. “I’ve got maybe two days of medication left, and I can’t get a human on the phone,” he wrote. I knew the feeling intimately because I was living the same thing at week 16 of my own treatment.

I had two days of medication left. I needed to know whether to bridge with a partial dose or skip a week entirely. I submitted a support ticket. I tried chat. I got back a form response twelve hours later that didn’t answer my question. I ended up bridging on my own judgment, which worked out fine, but that moment crystallized something: I was relying on a provider whose operational backbone couldn’t keep up with what its marketing promised.

That was the decisive event. Everything before it was accumulating friction.

How the First Few Months Went (and Why I Stayed Too Long)

I started with Hims because the brand was familiar from their men’s health products, onboarding was frictionless, the pricing looked competitive, and the whole experience had that polished DTC sheen. The first month was genuinely fine. Medication arrived on schedule. The consult was professional. Dose progression was standard.

The cracks showed around month three. Customer service got slower. Shipping windows stretched. When I asked which 503B pharmacy was supplying my medication, the answer got vaguer each time. None of these were dealbreakers by themselves. Together they painted a picture of a company growing faster than its operations could absorb. Like a restaurant that got a great review and now has a 90-minute wait but the same kitchen staff.

Here’s the thing: I stayed because switching felt like more work than tolerating the annoyances. That’s a trap. The friction of switching is real but temporary. The friction of staying with a deteriorating provider compounds every single month.

The Checklist I Wish I’d Built Before Signing Up the First Time

After the shipping debacle, I built a set of criteria for the next provider. Specific, verifiable stuff, not vibes:

Pharmacy transparency. A specific named 503A or 503B compounding pharmacy I could look up independently. Not a claim on a website. The actual name.

Prescriber access. A consultation that was substantive, not perfunctory. And the ability to reach the prescriber directly when a clinical question came up, not route everything through a general support inbox.

Transparent pricing. The all-in monthly number. No hidden consult fees, no shipping surprises, no commitment lock-ins that punish you for leaving.

Customer service you can actually test. Real response times, ideally with phone access. I wanted to verify this before committing, not discover it during a crisis.

Supply chain reliability. Demonstrated, not aspirational.

Five Providers, Three Intakes, One Winner

I evaluated five providers against that list. I went through public information on each, read patient reviews across multiple platforms, and started the intake process on three of them to gauge consult quality before committing.

The provider I switched to was FormBlends. Here’s what separated them in practice:

The intake process asked the right questions. Thorough medical history, contraindication screening, a real conversation about treatment goals. The prescriber I spoke with wanted to understand my previous medication history and walked through the rationale for the dose progression we agreed on. That conversation alone told me more about clinical seriousness than anything on a marketing page.

The pricing was the actual number. Not a teaser rate that would creep upward after three months. Shipping, consult, follow-ups, and the medication itself, all one transparent monthly cost.

I tested customer service before fully committing. Sent a series of routine questions over a few days to see how quickly they responded and whether the answers were templated or specific. They were specific. They were fast. That alone would have been enough after what I’d been through.

How I Actually Made the Switch Without a Gap in Treatment

Switching telehealth GLP-1 providers is not like transferring a prescription at CVS. The prescription is typically tied to the provider, not portable. You can’t just call and say “send my script to the new place.”

What I did, in order:

I confirmed with the new provider that they could prescribe at my current dose. This avoids unnecessary titration disruption, which matters more than most people realize.

I scheduled the new intake to overlap with my last month at Hims by about a week.

I notified Hims I was canceling future shipments, confirmed the cancellation, and verified no pending charges.

I started the new provider’s shipment cycle with roughly ten days of medication still on hand from the old provider. Buffer.

The transition was clean. No dose changes, no gap, no retitration. If you plan it with a week of overlap, the whole thing is uneventful. The anxiety about switching is worse than the actual switching.

What’s Different Now (Honestly)

The most immediate change was responsiveness. Messages answered in hours, not days. And the answers were specific to my situation, not copied from a knowledge base.

The second change was supply chain clarity. When I asked which compounding pharmacy was producing my medication, I got a specific answer I could verify independently. This isn’t trivia. If you ever need to track down a manufacturing question or confirm the regulatory status of what you’re injecting, that information matters.

The third change was the prescriber relationship. Routine medication reviews happen on a defined schedule. When I had a question about a GI side effect at week six with the new provider, I could send it directly to my prescriber. Not a chatbot. Not a support inbox. The prescriber. This sounds small. It’s the difference between feeling like a patient and feeling like a subscriber.

The cost was roughly equivalent. Hims was running me about $300 a month. The new provider was $279. Price wasn’t the driver. But it wasn’t worse, either.

What I’d Tell Someone Starting Fresh

Do the evaluation work before you pick your first provider, not after you’ve been burned. I treated my initial choice as low-stakes because Hims was a brand I recognized. Bad framework. The provider you pick for ongoing GLP-1 therapy is a decision you live with monthly, for as long as you’re on treatment.

Ask the supply chain question upfront. The provider who gives a clear, specific answer about who manufactures your medication is the one you want. The provider who treats that question as proprietary or dodges it? Walk away.

Understand prescription portability before you commit. Some providers will release a prescription you can take elsewhere. Some won’t, and you only discover this when you try to leave. Knowing this upfront would have changed my first provider choice entirely.

The Boring Truth About This Market

The telehealth GLP-1 space is a spectrum. On one end, legitimate medical practices that happen to use telehealth as the delivery mechanism. On the other end, logistics companies that route medications through a thin layer of clinical oversight. The marketing often looks identical.

The patient’s job is to do verification work the market doesn’t do for you. Check certifications independently. Ask the pharmacy questions. Test customer service before you need it urgently. Read the cancellation terms before you sign up. None of this is excessive due diligence for a medication you’ll take weekly for many months.

My opinion, and I’ll own it: the patients who treat provider selection as a real decision consistently have better experiences than the patients who default to whichever provider showed up in their Instagram feed first. The algorithm is not your doctor.

If you’re happy with your current provider, this post isn’t telling you to switch. If you’re not happy, switching is more feasible than the friction makes it feel. The work concentrates in one week. The benefit, if you choose carefully, runs for the duration of treatment.

Frequently Asked Questions

How do I verify that a compounding pharmacy is legitimately licensed? Check your state’s board of pharmacy database for the specific pharmacy name. For 503B outsourcing facilities, the FDA maintains a public list of registered facilities. Ask your provider for the pharmacy name directly. If they won’t give it to you, that tells you something.

Will I have a gap in medication when I switch providers? Not if you plan ahead. Schedule your new provider intake about a week before your last shipment from the old provider runs out. This overlap gives you buffer for any onboarding delays with the new provider.

Is compounded tirzepatide the same as Mounjaro or Zepbound? Compounded tirzepatide contains the same active ingredient but is not FDA-approved and is prepared by compounding pharmacies rather than the brand manufacturer (Eli Lilly). The regulatory pathway, manufacturing oversight, and formulation may differ. Your prescriber should discuss these distinctions with you.

What should I ask a new provider during the intake consultation? Five questions that separate serious providers from the rest: Which compounding pharmacy prepares the medication? What is the total monthly cost including all fees? Can I communicate directly with my prescriber? What are your shipping timelines and how do you handle delays? What is your cancellation policy?

How long does the switching process typically take? From first contact with a new provider to receiving your first shipment, expect about one to two weeks. The intake consultation itself is usually completed within a few days. Factor in shipping time and plan your overlap accordingly.

Leave a Reply

Your email address will not be published. Required fields are marked *